Expert Speaker Faculty

Take a look at the esteemed speaker faculty for the 5th Operationalise: Early Access Programmes Summit Europe.

Pharma Thought Leaders
Biotech Thought Leaders
Patient & Advocacy Voices
Trusted Partners

Pharma Thought Leaders

Ahmed Hnoosh - 5th Operationalise Early Access Programmes Europe

Ahmed Hnoosh

Director - Worldwide Health Economics & Outcomes Research
Bristol Myers Squibb
Ann Watkins - 5th Operationalise Early Access Programmes Europe

Ann Watkins

Associate Director, Medical Affairs, EUR/International
Jazz Pharmaceuticals plc
Antoine Robert - 5th Operationalise Early Access Programmes Europe

Antoine Robert

Global Post-Trial Access Lead
Sanofi
Cassandra Slader - 5th Operationalise Early Access Programmes Europe

Cassandra Slader

Global Head of Managed Access Programs
UCB
Catherine Singfield - 5th Operationalise Early Access Programmes Europe

Catherine Singfield

Senior Director, Head of EUR/INT Medical, Evidence Optimisation & Managed Access Programmes Team
Jazz Pharmaceuticals plc
Dan Weeks - 5th Operationalise Early Access Programmes Europe

Dan Weeks

Head of Global Access Mechanisms
Biogen
Jason Cameron - 5th Operationalise Early Access Programmes Europe

Jason Cameron

Associate Director
Bristol Myers Squibb
Karolina Gliwska - 5th Operationalise Early Access Programmes Europe

Karolina Gliwska-Szałankiewicz

Director Evidence Operations, Oncology Business Unit Medical Evidence
AstraZeneca
Michael Al-Rachid - 5th Operationalise Early Access Programmes Europe

Micheal Al-Rachid

Associate Director, Commercial Operations & Business Intelligence
Eisai Co., Ltd.
Olga Andreea - 5th Operationalise Early Access Programmes Europe

Olga Andreeva

Head of Expanded Access Center of Excellence
Novo Nordisk
Ozlem Yilman - 5th Operationalise Early Access Programmes Europe

Ozlem Yilmaz

Head, Medical Affairs (Growth Markets; Central Eastern Europe & Middle East & North Africa)
Eisai Co., Ltd.
Pedro Franco - 5th Operationalise Early Access Programmes Europe

Pedro Franco

Senior Director & Head of Europe Global Regulatory & Scientific Policy,
Merck KGaA
Rachel Harrison - 5th Operationalise Early Access Programmes Europe

Rachel Harrison

Director - Pre-Approval, Post-Trial Access Programs, Medical Affairs & Evidence Generation
Argenx
Ramona Reichenbach - 5th Operationalise Early Access Programmes Europe

Ramona Reichenbach

Head Managed Access & Medical Policy
Novartis AG
Vilem Guryca - 5th Operationalise Early Access Programmes Europe

Vilem Guryca

Director, Expanded Access, Global Medical Affairs
BeOne Medicines

Biotech Thought Leaders

Archit Kalra - 5th Operationalise Early Access Programmes Europe

Archit Kalra

Chief Executive Officer
Kalevala Therapeutics, Inc.
Arzu Mulayim - 5th Operationalise Early Access Programmes Europe

Arzu Mulayim

Senior Medical Director, Mid Sized European Countries
ACADIA Pharmaceuticals Inc.
Ceren Guzelalp - 5th Operationalise Early Access Programmes Europe

Ceren Guzelalp

Director, Early Access & Patient Support, Europe
ACADIA Pharmaceuticals Inc.
Claire Ramer - 5th Operationalise Early Access Programmes Europe

Claire Ramer

Associate Director, Global Medical Affairs Operations,
Deciphera Pharmaceuticals, Inc
Clare Baker - 5th Operationalise Early Access Programmes Europe

Clare Baker

Senior Director, Head of Medical Excellence & Operations
Sobi
Corinde Staring - 5th Operationalise Early Access Programmes Europe

Corinde Staring

Associate Director Evidence Generation
Genmab
Peter Takacs - 5th Operationalise Early Access Programmes Europe

Dr. Peter Takacs

Global Head of Market Access
Miletenyi Biomedicine
Flavie Faist - 5th Operationalise Early Access Programmes Europe

Flavie Faist

Country Medical Director
H. Lundbeck A/S
Gianluca Parziale - 5th Operationalise Early Access Programmes Europe

Gianluca Parziale

Associate Legal Director, Italy and Benelux
Alnylam Pharmaceuticals
Nora Pontynen - 5th Operationalise Early Access Programmes Europe

Nora Pöntynen

Senior Medical Advisor
LEO Pharma A/S

Patient & Advocacy Voices

Harpreet Ram - 5th Operationalise Early Access Programmes Europe

Harpreet Ram

President & Executive Director
GARDaccess
Robert Mitchell-Thain - 5th Operationalise Early Access Programmes Europe

Robert Mitchell-Thain

Chief Executive Officer
The PBC Foundation Ltd.
Walter Colsanate - 5th Operationalise Early Access Programmes Europe

Walter Colsanate

Co-Founder & Lead
The Medicine Access Channel

Trusted Partners

Dennis Akkaya - 5th Operationalise Early Access Programmes Europe

Dennis Akkaya

Chief Commercial Officer
myTomorrows
Panel Discussion
Explore the Agenda

Discover exactly how leading teams are solving the hardest Early Access challenges - from pathway selection and global delivery to data, supply, and long-term sustainability.

Full Event Guide
Panel Discussion
Partner With Us

Position your solutions in front of decision-makers actively looking to scale and optimise Early Access Programmes, and become a trusted partner in delivering access worldwide.

Explore Sponsorship Options
Networking
Join Early Access Leaders

Connect with the EAP community shaping how access is delivered today, exchange real challenges, and learn directly from peers running programmes across global markets. 

Secure Your Pass